Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6222114rdf:typepubmed:Citationlld:pubmed
pubmed-article:6222114lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0085820lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C1155003lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0021755lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0034304lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C2244956lld:lifeskim
pubmed-article:6222114lifeskim:mentionsumls-concept:C0079411lld:lifeskim
pubmed-article:6222114pubmed:issue6lld:pubmed
pubmed-article:6222114pubmed:dateCreated1983-7-8lld:pubmed
pubmed-article:6222114pubmed:abstractTextThe role of factors released by monocytes (M phi) in the activation of human B lymphocytes was examined by studying the effect of an antiserum against human leukocytic pyrogen (LP) on mitogen-stimulated B cell proliferation and the generation of immunoglobulin-secreting cells (ISC) by peripheral blood mononuclear cells (PBM). Antiserum against LP was obtained from rabbits immunized with LP-containing human M phi supernatants. The globulin fraction of this antiserum inhibited pokeweed mitogen- (PWM) stimulated B cell proliferation and the generation of ISC in a concentration-dependent manner, with 50% inhibition of responsiveness observed with 10 micrograms/ml. By contrast, PWM-induced T cell [3H]thymidine incorporation was not inhibited by concentrations of anti-LP as great as 2000 micrograms/ml. The F(ab')2 fraction of anti-LP also inhibited the generation of ISC in response to both PWM and formalinized Staphylococcus aureus, but required 50 micrograms/ml to achieve 50% inhibition. Anti-LP inhibited the generation of ISC only if present during the first 24 hr of a 6 to 7-day incubation; later addition was not inhibitory. Inhibition was more marked in cultures partially depleted of M phi than in whole PBM cultures. Whereas absorption of the anti-LP with PBM failed to remove the capacity to inhibit the generation of ISC, anti-LP-mediated inhibition of responsiveness could be reversed by the addition of crude M phi culture supernatants or a variety of highly purified interleukin 1 (IL 1) preparations, but not by T cell supernatants. These results indicate anti-LP inhibits human B cell activation by removing the requisite M phi-derived factor IL 1 and also confirm that IL 1 plays an essential role in B cell proliferation and the generation of ISC in man.lld:pubmed
pubmed-article:6222114pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:languageenglld:pubmed
pubmed-article:6222114pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:citationSubsetAIMlld:pubmed
pubmed-article:6222114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6222114pubmed:statusMEDLINElld:pubmed
pubmed-article:6222114pubmed:monthJunlld:pubmed
pubmed-article:6222114pubmed:issn0022-1767lld:pubmed
pubmed-article:6222114pubmed:authorpubmed-author:DinarelloC...lld:pubmed
pubmed-article:6222114pubmed:authorpubmed-author:ThompsonP APAlld:pubmed
pubmed-article:6222114pubmed:authorpubmed-author:LipskyP EPElld:pubmed
pubmed-article:6222114pubmed:authorpubmed-author:RosenwasserL...lld:pubmed
pubmed-article:6222114pubmed:issnTypePrintlld:pubmed
pubmed-article:6222114pubmed:volume130lld:pubmed
pubmed-article:6222114pubmed:ownerNLMlld:pubmed
pubmed-article:6222114pubmed:authorsCompleteYlld:pubmed
pubmed-article:6222114pubmed:pagination2708-14lld:pubmed
pubmed-article:6222114pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:meshHeadingpubmed-meshheading:6222114-...lld:pubmed
pubmed-article:6222114pubmed:year1983lld:pubmed
pubmed-article:6222114pubmed:articleTitleThe role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen.lld:pubmed
pubmed-article:6222114pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6222114pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6222114lld:pubmed